All In MedTech

FDA Clearance Tracker · DEN140025

BrainScope Ahead 100

A De Novo grant creates a new device type for a low to moderate risk device with nothing on the market to compare it to. Later devices of this type can use it as their comparison in a 510(k).

Last checked: Nov 20, 2026Latest source record: Nov 17, 2014 (this decision)Source: openFDAMethods & limitations

De NovoNew device type

The decision

FDA number
DEN140025
Device name
BrainScope Ahead 100
Applicant location
Bethesda, MD
Received
Aug 20, 2014
Decided
Nov 17, 2014
Decision
De Novo granted
Submission type
Direct
Expedited review
Yes, flagged as expedited in FDA's record.

Device type

Device class
Class II
Regulation
21 CFR 882.1450

Every decision under product code PIW

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Brainscope Company, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.